Kia ora

  

Thank you for your request for official information. The reference number
for your request is: H2024041059

  

As required under the Official Information Act 1982, Manatū Hauora will
endeavour to respond to your request no later than 20 working days after
the day your request was received. If you'd like to calculate the
timeframe, you can use the Ombudsman's online calculator
here: [1]http://www.ombudsman.parliament.nz/  

  

If you have any queries, please feel free to contact the OIA Services Team
on [2][email address]. If any additional factors come to light which
are relevant to your request, please do not hesitate to contact us so that
these can be taken into account.  

Under section 28(3) of the Act you have the right to ask the Ombudsman to
review any decisions made under this request. The Ombudsman may be
contacted by email at: [3][email address] or by calling 0800
802 602.

 

Ngā mihi 

 

OIA Services Team 

[4]Ministry of Health information releases 

 

 

------------------- Original Message -------------------
From: ASE <[FOI #26670 email]>; 
Received: Wed May 08 2024 13:47:03 GMT+1200 (New Zealand Standard Time)
To: OIA Requests <[email address]>; OIA <[email address]>; 
Subject: Official Information request - Differences between BNT162b2 and
Comirnaty®

Attn Ministry of Health,

I am seeking information regarding substantive differences between
BNT162b2 and Comirnaty®.

Both products have variously been referred to as “COVID-19 vaccines” and
“vaccine candidates”.

1- Are/were the same manufacturing processes used to manufacture
Comirnaty® and BNT162b2? Has The Ministry of Health confirmed such
information with the manufacturer/supplier?

2- What information is held by The Ministry of Health regarding
similarities and differences between the manufacturing processes of
BNT162b2 and Comirnaty®?

3- Are there any quantifiable differences between BNT162b2 and Comirnaty®,
eg regarding the use or presence of SV40 sequences, the presence of DNA,
the integrity of synthetic mRNA, the use of methyl-pseudouridine, or any
other quantifiable differences?

Thank you,
ASE

 

****************************************************************************
Statement of confidentiality: This e-mail message and any accompanying
attachments may contain information that is IN-CONFIDENCE and subject to
legal privilege.
If you are not the intended recipient, do not read, use, disseminate,
distribute or copy this message or attachments.
If you have received this message in error, please notify the sender
immediately and delete this message.
****************************************************************************

References

Visible links
1. http://www.ombudsman.parliament.nz/
2. mailto:[email address]
3. mailto:[email address]
4. https://www.health.govt.nz/about-ministr...

hide quoted sections

Kia ora ASE,

 

Please find attached our response to your official information request.

 

Ngā mihi 

  

 

OIA Services Team

Manatū Hauora | Ministry of Health

M[1]inistry of Health information releases 
U[2]nite against COVID-19 

 

****************************************************************************
Statement of confidentiality: This e-mail message and any accompanying
attachments may contain information that is IN-CONFIDENCE and subject to
legal privilege.
If you are not the intended recipient, do not read, use, disseminate,
distribute or copy this message or attachments.
If you have received this message in error, please notify the sender
immediately and delete this message.
****************************************************************************

References

Visible links
1. https://www.health.govt.nz/about-ministr...
2. https://covid19.govt.nz/

hide quoted sections

Kia ora ASE,

 

Thank you for your request for official information. The Ministry's
reference number for your request is: H2025059109.  

 

Please be advised that due dates for requests received from 27 November
2024 onwards will take into account the summer holidays (25 December 2024
to 15 January 2025). Please refer to this guide for an explanation of
the [1]statutory obligations under the Official Information Act 1982.  

 

You can expect a reply no later than 24 February. If we are unable to
respond to your request within this time frame, we will notify you of an
extension of that time frame.

 

If you have any queries related to this request, please do not hesitate to
get in touch. 

Ngā mihi 
 
OIA Services Team 
[2]Ministry of Health information releases 

 

 

 

Attn, Ministry of Health

As this Ministry is responsible for assuring the safety and efficacy of
approved medical interventions in NZ,

And as pharmaceutical and especially biological safety regulations widely
recognises that “the process is the product”,

I expect that the Ministry can provide a substantive answer, rather than
deferring to common industry practice. If the Ministry of Health can not
directly answer this question, then please clearly state that.

Did the manufacturing processes used to obtain any kind of regulatory
approval for any “COVID-19 vaccines” and covid “vaccine candidates”
significantly and materially change since the applications for approval
were first submitted?

As more reports have been indicating that manufacturing methods did
significantly change subsequent to applications for approval being made,
what actions has the Ministry of Health taken to investigate such claims?
eg, has the Ministry of Health directly questioned the suppliers,
applicants, and other stakeholders about this?

Thank you,
ASE

****************************************************************************
Statement of confidentiality: This e-mail message and any accompanying
attachments may contain information that is IN-CONFIDENCE and subject to
legal privilege.
If you are not the intended recipient, do not read, use, disseminate,
distribute or copy this message or attachments.
If you have received this message in error, please notify the sender
immediately and delete this message.
****************************************************************************

References

Visible links
1. https://www.ombudsman.parliament.nz/reso...
https://www.ombudsman.parliament.nz/reso...
2. https://www.health.govt.nz/about-ministr...

hide quoted sections

Kia ora ASE

 

Please see attached a response to your request for official information.

 

 

Ngā mihi 

  

 

OIA Services Team

Manatū Hauora | Ministry of Health

M[1]inistry of Health information releases 

 

****************************************************************************
Statement of confidentiality: This e-mail message and any accompanying
attachments may contain information that is IN-CONFIDENCE and subject to
legal privilege.
If you are not the intended recipient, do not read, use, disseminate,
distribute or copy this message or attachments.
If you have received this message in error, please notify the sender
immediately and delete this message.
****************************************************************************

References

Visible links
1. https://www.health.govt.nz/about-ministr...

hide quoted sections